🎉 M&A multiples are live!
Check it out!

Disc Medicine Valuation Multiples

Discover revenue and EBITDA valuation multiples for Disc Medicine and other public comps.

See Disc Medicine Valuation Multiples

Disc Medicine Overview

About Disc Medicine

Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.


Founded

2015

HQ

United States of America
Employees

74

Financials

LTM Revenue n/a

LTM EBITDA -$141M

EV

$1.4B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Disc Medicine Financials

Disc Medicine has a last 12-month revenue of n/a and a last 12-month EBITDA of -$141M.

In the most recent fiscal year, Disc Medicine achieved revenue of n/a and an EBITDA of -$91.0M.

Disc Medicine expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Disc Medicine valuation multiples based on analyst estimates

Disc Medicine P&L

FY 2022 FY 2023 FY 2024 LTM NTM
Revenue n/a n/a n/a n/a XXX
Gross Profit n/a n/a n/a XXX XXX
Gross Margin NaN% NaN% NaN% XXX XXX
EBITDA -$47.4M -$91.0M -$132M -$141M XXX
EBITDA Margin -Infinity% -Infinity% -Infinity% -Infinity% XXX
Net Profit -$71.9M -$46.8M -$76.4M XXX XXX
Net Margin -Infinity% -Infinity% -Infinity% XXX XXX
Net Debt n/a n/a n/a XXX XXX

Financial data powered by Morningstar, Inc.

Disc Medicine Stock Performance

As of February 10, 2025, Disc Medicine's stock price is $55.

Disc Medicine has current market cap of $1.9B, and EV of $1.4B.

See Disc Medicine trading valuation data

Disc Medicine Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.4B $1.9B XXX XXX XXX XXX $-4.24

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Disc Medicine Valuation Multiples

As of February 10, 2025, Disc Medicine has market cap of $1.9B and EV of $1.4B.

Disc Medicine's trades at n/a LTM EV/Revenue multiple, and -9.9x LTM EBITDA.

Analysts estimate Disc Medicine's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Disc Medicine and 10K+ public comps

Disc Medicine Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $1.4B XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA -10.6x XXX XXX XXX
P/E -16.5x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Disc Medicine Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Disc Medicine Valuation Multiples

Disc Medicine's NTM/LTM revenue growth is Infinity%

Disc Medicine's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $1.2M for the same period.

Over next 12 months, Disc Medicine's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Disc Medicine's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Disc Medicine and other 10K+ public comps

Disc Medicine Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth n/a XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth 45% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee $1.2M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue n/a XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Medical Devices
Consumer SaaS
Streaming Platforms
AdTech Software
Climate Tech
GRC Software
Developer Tools

Disc Medicine Public Comps

See valuation multiples for Disc Medicine public comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Disc Medicine M&A and Investment Activity

Disc Medicine acquired  XXX companies to date.

Last acquisition by Disc Medicine was  XXXXXXXX, XXXXX XXXXX XXXXXX . Disc Medicine acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Disc Medicine

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Disc Medicine

When was Disc Medicine founded? Disc Medicine was founded in 2015.
Where is Disc Medicine headquartered? Disc Medicine is headquartered in United States of America.
How many employees does Disc Medicine have? As of today, Disc Medicine has 74 employees.
Who is the CEO of Disc Medicine? Disc Medicine's CEO is Dr. John D. Quisel, J.D.,PhD.
Is Disc Medicine publicy listed? Yes, Disc Medicine is a public company listed on NAS.
What is the stock symbol of Disc Medicine? Disc Medicine trades under IRON ticker.
When did Disc Medicine go public? Disc Medicine went public in 2021.
Who are competitors of Disc Medicine? Similar companies to Disc Medicine include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Disc Medicine? Disc Medicine's current market cap is $1.9B
What is the current EBITDA of Disc Medicine? Disc Medicine's last 12-month EBITDA is -$141M.
What is the current EV/EBITDA multiple of Disc Medicine? Current EBITDA multiple of Disc Medicine is -9.9x.
Is Disc Medicine profitable? Yes, Disc Medicine is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.